Loren Data Corp.

'

 
 

COMMERCE BUSINESS DAILY ISSUE OF APRIL 6,1995 PSA#1319

National Institutes of Health, Division of Procurement, AB-A 6120 Executive Blvd., Room 890, Rockville, MD 20892

66 -- MAGNETIC RESONANCE IMAGING (MRI) SOL 263-95-P(GD)-0032 POC Donald Wilson, Contract Specialist, (301) 402-2849. 17. The National Institutes of Health intends to negotiate with Invivo Research INC, 12601 Research PKWY, Orlando, FL 32826 as a sole source under the authority of 41. U.S.C. 253(c)(1), for a Omnitrak MRI (PMS) Patent Monitoring System model number 3100 (install), including model numbers 3112-1, 3111-2, 90399, 9050M, 9060M, 9070M, 9238, 9239, 918OT, 9010D, 9010F, 9012, 9013, and 9014. The Magnetic Resonance Imaging (MRI) monitoring system, shall be as manufactured in accordance with the functional/performance characteristics herein as follows: The NIH Laboratory of Diagnostic Radiology Research requires a Magnetic Resonance Imaging (MRI) monitoring system, to work in conjunction with the Government owned G.E. Signa 1.5 Telsa Magnet. 1. The system shall be compatible with and provide cardiac, and respiratory gating, for the G.E Signa 1.5 Telsa MRI unit. It shall have low and nonferrous content in filtering and circuitry to permit interference free MRI scanning, and clear, stable ECG waveforms. It shall be designed to minimize the risk of burns to patients from radio frequency current generated by the MR unit. 2. Shall be designed to provide continuous, accurate monitoring for all patients from neonates to adults during magnetic resonance imaging. 3. The system components and all accessories shall be fully compatible and operate as a complete patient monitoring system both inside and outside the magnet room. 4. The system shall have the capability of monitoring the following physiological parameters, ECG, respiration, non- invasive blood pressure, end-tidal CO2, SpO2 and pulse rate. It shall include a printer, MR cabling, remote monitor, monitor cart, pulse oximeter, and end-tidal CO2 analyzer, and pre-installation items. 5. The non-invasive blood pressure monitor shall have a pressure range of 0-255 torr for adult and pediatric patients, and 0- 210 torr for neonates, and pulse rate accuracy of 0.2% of full scale. 6. The ECG amplifier shall allow 4 lead configurations, I, II, AVL, AVR, or AVF with an accuracy of +0.5%. The recorder shall have dual channel, 50mm/s display. 7. The pulse oxymeter shall have a pulse rate range of 20-250 bpm, and 0.2% accuracy or greater at 90-100% saturation. 8. The CO2/N2O module shall measure ranges of 0-76mmHg for CO2 with 3mmHg. accuracy, and 0-99% for N2O with full scale accuracy of 0.5%. 9. It shall include installation and testing of all components by factory trained systems technicians. 10. The system shall have FDA approval and conform to the Joint Commission on Accreditation of Healthcare Organization (JCAHO) guidelines for monitoring sedated and anesthetized patients. It shall have high and low alarms for systolic and diastolic blood pressure and heart rate. 11. The system shall be capable of both close and remote monitoring and provide complete patient documentation. 12. The system shall offer preprogrammed and manual options for setup and configuration. This shall include automatic blood pressure measurements taken at intervals selectable by the user for adult, pediatric and neonatal patients. It is the Government's belief that these requirements can be met by Invivo Research INC. This is not a formal solicitation. However, concerns that respond to this notice must furnish concise responses directed specifically to the requirements mentioned above. Sources demonstrating the capability to accomplish the above shall supply pertinent information in sufficient detail to demonstrate that ability to perform. Information furnished shall include enough material to perform a proper evaluation. Respondents will not be notified of the evaluation results. See note 22: (0094)

Loren Data Corp. http://www.ld.com (SYN# 0374 19950405\66-0001.SOL)


66 - Instruments and Laboratory Equipment Index Page